This inventor holds 2 USPTO granted patents. Top assignee: Mcmaster University. Active years: 2006-2009.
Location History:
- Canning Vale WA, AU (2006)
- Canning, AU (2009)
Company Filing History:
Years Active: 2006-2009
Title: John Eikelboom: Innovator in Cardiovascular Health
Introduction
John Eikelboom is a notable inventor based in Canning, Australia. He has made significant contributions to the field of cardiovascular health through his innovative patents. With a total of 2 patents, Eikelboom's work focuses on methods and devices that enhance the detection and prediction of cardiovascular events.
Latest Patents
Eikelboom's latest patents include a "Device for measuring an analyte" and a "Method for predicting cardiovascular events." The device provides a novel method for detecting the concentration of a metabolite in a fluid sample. Specifically, it allows for the determination of urinary 11-dehydro thromboxane concentration, which is crucial for assessing the risk of recurrent cardiovascular events. The method for predicting cardiovascular events assesses aspirin resistance by measuring the concentration of 11-dehydro-thromboxane B2 in urine samples. This measurement is compared to standardized quartile concentrations to evaluate the risk of cardiovascular events in patients taking aspirin.
Career Highlights
Eikelboom is affiliated with McMaster University, where he continues to advance research in cardiovascular health. His work has garnered attention for its potential to improve patient outcomes through better risk assessment and monitoring.
Collaborations
Eikelboom has collaborated with esteemed colleagues such as Salim Yusuf and Jack Hirsh. Their combined expertise has contributed to the development of innovative solutions in the field of cardiovascular medicine.
Conclusion
John Eikelboom's contributions to cardiovascular health through his patents and research are invaluable. His innovative approaches to measuring and predicting cardiovascular risks have the potential to significantly impact patient care and outcomes.